A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma

Published:2012-09 Issue:3 Volume:77 Page:567-571
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Dowell Jonathan E.,Dunphy Frank R.,Taub Robert N.,Gerber David E.,Ngov Likheng,Yan Jingsheng,Xie Yang,Kindler Hedy Lee

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

2. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy;Dvorak;J Clin Oncol,2002

3. Evaluation of tumor angiogenesis as a prognostic marker in malignant mesothelioma;Kumar-Singh;J Pathol,1997

4. Angiogenesis is an independent prognostic factor in malignant mesothelioma;Edwards;Br J Cancer,2001

5. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression;Kumar-Singh;J Pathol,1999

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Mesothelioma;Current Pulmonology Reports;2024-05-23

2. Prise en charge diagnostique et thérapeutique du mésothéliome pleural en 2023;Revue des Maladies Respiratoires Actualités;2023-10

3. Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model;International Journal of Molecular Sciences;2023-08-04

4. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis;Diagnostics;2022-11-25

5. Prise en charge diagnostique et thérapeutique du mésothéliome pleural malin en 2022;Revue des Maladies Respiratoires Actualités;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3